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Indomethacin at a concentration (1O-4 M) which depressed the effect on O,- generation by fMet-Leu-Phe, 
markedly enhanced 0; generation by both I-oleoyl-2-acetylglycerol and the calcium ionophore. A23187. 
These results are explicable in terms of the hypothesis that synergism between cytosolic calcium and protein 
kinase C is involved in signal transduction for the respiratory burst in the human eutrophil. 
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1. INTRODUCTION 
When neutrophils are exposed to certain stimuli, 
their 02 uptake increases (the ‘respiratory burst’) 
and large amounts of superoxide (Oi-) are 
generated [I 1. This reaction leads to the formation 
of other toxic oxygen products which are impor- 
tant in the killing of microbes (review [l]) and 
which may well be implicated in tissue damage in 
complex-mediated isease [2]. However, as em- 
phasized in a recent review [3], the events involved 
in signal transduction for the respiratory burst are 
not yet fully understood. 
Nishizuka has recently proposed that two 
events - generation of the protein kinase C ac- 
tivator, DAG, and an increase in cytosolic calcium 
- may be involved in stimulus-activation coupling 
in various cell types and that the two pathways 
may function synergistically [4]. Recently we 
reported synergism between the synthetic 
diacylglycerol, OAG, and the calcium ionophore, 
A23 187, in superoxide generation in the neutrophil 
[S]. Similar studies in which the tumor promoter, 
PMA, was used as the protein kinase C activator, 
Abbreviations: OAG, I-oleoyl-2-acetylglycerol; DAG, 
d~wk~werol; PMA, phorbol myristate acetate; PI, 
phosphatidylinositol 
had been previously reported by us [6] and by 
others [7,8]. We have also recently reported [9] 
that prostaglandins of the E series, which are 
believed to stimulate adenyl cyclase, had an unex- 
pected enhancing effect on OAG-induced superox- 
ide generation, whereas they decreased fMet-Leu- 
Phe-induced Oi- production and had no effect on 
Oi- production by PMA or A23187. 
Here we report that indomethacin, one of the 
main non-steroidal anti-inflammatory drugs, also 
has unexpected enhancing actions on Oi- genera- 
tion. This drug has completely different effects on 
Oi- production depending on the method of 
stimulation used. Thus indomethacin has a consis- 
tent and marked inhibitory effect, if Oi- is 
generated as a result of receptor-activation with 
fMet-Leu-Phe, whereas it has a marked enhancing 
effect if Oi- is generated by direct activation of 
either of the two pathways specified above. We 
suggest hat these results can be explained on the 
basis of inhibition by indomethacin of the 
metabolism of OAG and DAG by diacylglycerol 
lipase. 
2. MATERIALS AND METHODS 
Neutrophils were collected from human 
volunteers by venipuncture, prepared by Ficoll- 
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Isopaque separation as described [6] and suspend- 
ed in calcium-free Tyrode solution containing 
137 mM NaCl, 2.7 mM KCI, 1 mM MgC12, 
1 mg/ml glucose and 1 mg/ml bovine serum 
albumin. 
The cells were equilibrated for 20 min at 37°C; 
to those cells which were to be stimulated with 
either fMet-Leu-Phe or A23187, cytochalasin B 
(10 yg/ml) was then added. After a further 10 min 
incubation, 2.5 x lo6 cells were dispensed into 
tubes containing 1 mg ferricytochrome c (horse 
heart type III, Sigma), 10e4 M indomethacin and 
either Tyrode solution or 75 units superoxide 
dismutase (bovine blood, Sigma). Following a 
20 min incubation, appropriate dilutions of OAC, 
A23187 or fMet-Leu-Phe were added to the cells. 
The final calcium concentration in all samples was 
3 mM. After 30 min incubation at 37”C, the reac- 
tion was stopped by the addition of 1 mM N- 
ethylmaleimide (Sigma). Following centrifugation 
at 1400 x g for 10 min at 4”C, the absorbance of 
the supernatant was read at 550 nm in a Perkin 
Elmer SP-1800 spectrophotometer. The amount of 
Oi- produced was calculated by dividing the dif- 
ference in absorbance of the samples with and 
without superoxide dismutase by the extinction 
coefficient for the change between ferricytochrome 
c and ferrocytochrome c (E550nm = 15.5 mM-' . 
cm-‘) and the resulting value multiplied by 2000 to 
convert it to nmol Oi- per 5 x lo6 neutrophils. 
The effect of indomethacin on the Oi- response 
to a particular stimulant was calculated by taking 
the difference between Oi- production with and 
without indomethacin and expressing this dif- 
ference as a percentage of the maximum amount of 
Oi- generated by that particular stimulant. 
3. RESULTS 
In 6 experiments, 10-j M indomethacin con- 
sistently decreased fMet-Leu-Phe-induced Oi- 
generation, resulting in a markedly depressed dose- 
response curve (figs 1 and 2). A lower concentra- 
tion of indomethacin, 10m6 M, was without effect. 
In experiments with OAG, concentrations of 
1.1-2.3 x 1O-4 M gave maximum Oi- release. In 
8 experiments the mean maximum release with 
OAG alone was 46.89 (+ 6.4) nmol Oi- per 5 x 
10’ cells. In all these experiments 10-j M in- 
domethacin increased the Oi- generation pro- 
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Fig.1. The effect of indomethacin (IO-’ M) on Oi- 
generation with fMet-Leu-Phe, OAG and A23187. The 
results are given as the change in O;- production with 
indomethacin, expressed as a percentage of the 
maximum 0; obtained with each stimulant alone. The 
mean maximum response in nmol O;- per 5 X 10h cells 
was 25.7 (SE 1.9), 46.87 (SE 6.4) and 17.6 (SE 3.2), with 
fMet-Leu-Phe, OAG and A23187, respectively. The 
number of experiments is given in brackets. For fMet- 
Leu-Phe: a = 5 x IO-* M, b = 5 x lo-’ M. For OAG: 
a = 4.5 x lo-’ M, b = 6.8 x 10m5 M, c = 1.1 x 10mJ M. 
For A23187: a = lo-’ M, b = 5 x lo-’ M. 
. 
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Fig.2. The effect of indomethacin (lo-$ M) on O;- 
generation by fMet-Leu-Phe. fMet-Leu-Phe alone (o), 
with indomethacin (m). 
duced by submaximal concentrations of OAG and 
in 5 of the 8 experiments the maximal response was 
also increased. The increase of the OAG response 
by indomethacin, calculated as a percentage of the 
maximum response obtained with OAG is given in 
fig.1. In two experiments with OAG, several con- 
centrations of indomethacin were used and the ef- 
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Fig.3. (a) The effect of indomethacin, 10v4M, on Oj- 
generation with OAG. OAG alone (o), OAG in the 
presence of indomethacin (m). (b) The effect of 
indomethacin (lo-” M) on superoxide generation with 
A23187. A23187 alone (a), A23187 with indomethacin 
feet of the indomethacin was shown to be 
concentration-dependent, increasing over the con- 
centration range 10-6-10-4 M (not shown). 
Because normalization of measurements does not 
give a clear picture of the raw data, the results of 
an actual experiment are given in fig.3a. In two ex- 
periments, bromophenacyl bromide, 10v5 M, and 
mepacrine, 10e4 M (concentrations which inhibit 
the response to fMet-Leu-Phe), had no effect on 
the Oi- generation by OAG (not shown). 
The calcium ionophore, on its own, is a very 
poor stimulant of Oi- generation, only moderate 
effects being produced, even by high concentra- 
tions. In 5 experiments the maximum release with 
this agent was obtained with a concentration of 
5 x lo-’ M, the mean amount of Oi- generated 
being only 17.6 (+ 3.2) nmol per 5 x lo6 cells. In 
all these experiments, IOF M indomethacin in- 
creased the Oi- generation produced by high con- 
centrations of A23187. The potentiation of the 
response to A23187, given as a percentage of the 
maximum response, is shown in fig.1, and the 
results of an actual experiment in fig.3b. 
4. DISCUSSION 
Indomethacin cIearly has severa different ac- 
tions on the neutrophil. In low concentrations it in- 
hibits the cycle-oxygenase which converts 
arachidonate into cyclic endoperoxides [lo]. In 
higher concentrations it inhibits phospholipase AZ 
[1 1 J especially if the calcium concentration is low 
[12,13]. 
Previous studies have reported inhibitory effects 
of indomethacin on neutrophil Oi- generation 
with fMet-Leu-Phe [14,15]. Here, indomethacin 
decreased the response to fMet-Leu-Phe but 
caused an unexpected, marked enhancement of the 
response to the protein kinase C activator, OAG, 
and to the calcium ionophore A23187. The most 
likely reason for the effect on OAG is that in- 
domethacin inhibits the enzymes which metabolize 
OAG. It has been shown that OAG is metabolized 
rapidly in situ, presumably by the enzymes which 
metabolize endogenous DAG, such as DAG kinase 
141. DAG may also be deacetylated by a diglyceride 
Iipase j16J. Indomethacin has been shown to be a 
potent inhibitor in human platelets of diglyceride 
lipase but not diglyceride kinase [17). It may well 
be having a similar effect on this enzyme in 
neutrophils. We recently reported marked 
enhancement of OAG-mediated generation of Oi- 
in human neutrophils by PGEt and PGEz and sug- 
gested that this effect of these prostaglandins could 
be due to an inhibition of DAG kinase, although 
an alternative explanation of the effect seen with 
the prostagIandins could be inhibition of DAG 
Iipase. However, there is clearly a difference in the 
action of the prostagiandins and indomethacin, 
since, although both enhance the effect of OAG 
and decrease the effect of fMet-Leu-Phe on Oi- 
generation, they have different effects on ‘the 
calcium pathway’. PGEz does not modify 
A23187-mediated Oi- generation, whereas in- 
domethacin markedly increases it. It has already 
been established that a rise in intracellular Ca’+ per 
se is not a sufficient stimulus for Oi- generation 
[18] and that the additional stimulus is probably 
protein kinase C activation [5-SJ. How is it that, 
in the presence of indomethacin, a rise in cytosolic 
Ca2+ caused by A23187, now appears to be a very 
efficient stimulus for Oi- generation? An explana- 
tion of this effect of indomethacin based on the 
current model of the signal-transduction 
mechanism in cells such as the neutrophil [4,19,20] 
would be that the following sequence of events oc- 
curs: (1) the increased concentration of cytosoiic 
Ca2+, produced by A23187, stimulates generation 
215 
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of DAG by calcium-dependent enzymes, such as 
the phospholipase C responsible for the 
breakdown of PI [20,21]; (2) the DAG concentra- 
tion rises because indomethacin inhibits its 
degradation by inhibiting diglyceride lipase (and 
possibly diglyceride kinase); (3) subsequent 
synergism between the DAG pathway and the CaZf 
pathway results in Oi- gneration. 
A direct effect of the rise in cytosolic calcium on 
protein kinase C may participate in the response 
but is clearly not the main basis for it, because such 
a rise, in the absence of indomethacin, results in 
only a modest production of Oi-. 
If the mechanism of action of indomethacin in 
increasing Oi- production by OAG and A23187 is 
as suggested here it is apparently not mediated by 
adenyl cyclase, since indomethacin in the concen- 
trations used, does not increase cyclic AMP [22]. 
Furthermore, it is unlikely that the well 
documented effect of indomethacin on phospho- 
lipase A2 11 l- 131 is implicated in the action on 
OAG and A23187, since other phospholipase AZ 
inhibitors, such as bromophenacyl bromide and 
mepacrine (review [23]), were entirely without ef- 
fect on OAG-induced Oi- generation. 
Why do the E-type prostaglandins not have this 
effect on A23 187-induced Oi- generation, since, 
like indomethacin, they too enhance superoxide 
production by OAG? It could be a question of the 
degree of inhibition of OAG degradation caused 
by each agent. Another possibility is that the pros- 
taglandins, by increasing CAMP, could have some 
inhibitory effects on phospholipase C and thus on 
the generation of DAG, as has been proposed for 
both platelets [24] and neutrophils [25]. This 
would mean that, in the presence of the E-type 
prostaglandins, an A23187-mediated rise in 
cytosolic calcium would not result in an increase in 
DAG and thus would not result in increased Oi- 
production. 
Indomethacin probably has multiple effects on 
fMet-Leu-Phe-induced Oi- generation. For in- 
stance, it could decrease the affinity of the receptor 
or it could inhibit polyphosphoinositide turnover 
by inhibiting phospholipase C and/or DAG 
kinase. The effect of indomethacin found in this 
study, may explain the reported increase in O;- 
generation obtained with indomethacin in 
zymosan-stimulated neutrophils [26]. 
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